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Sir: Cryptococcosis is a rare oppor-
tunistic, invasive, fungal, life-
threatening infection, which occurs in
both immunocompetent and immu-
nocompromised patients. In
immunocompromised patients, the
signs of cryptococcosis can easily be
confused by the symptoms of the
primary disease, which may delay
adequate treatment [1].
We recently treated a 47-year-old
woman with a thymoma WHO type
B1 in the left hemithorax treated with
three cycles of cisplatin/etoposide.
Simultaneously, she developed a
recurrent right-sided pleural effusion,
which was drained four times and
tested by an India ink and gram-
stained smear, bacterial culturing,
Cryptococcus serum and pleural
punctuate antigen testing and a cyto-
logical stain, which were all negative
for microorganisms including Cryp-
tococcus neoformans. The
broncheoalveolar lavage (BAL)
material was also negative. The tran-
sudate contained lymphocytes and
mesothelial cells. Eight days follow-
ing the last cycle of chemotherapy,
the patient was admitted because of
fever, headache, neck pain, and cog-
nitive changes during chemotherapy-
induced pancytopenia. Three months
after pleural effusion development, C.
neoformans meningitis was diagnosed
in the cerebral spinal fluid. The
infection was successfully treated
with amphotericin B (0.7 mg/kg/day)
and flucytosine (100 mg/kg/day) for
2 weeks, followed by 8 weeks amfo-
tericin B (0.7 mg/kg/day) with
flucanozole (800 mg/kg/day). Despite
the diagnosis of meningeal
cryptococcosis, pleural abnormalities
remained attributed to the thymoma.
Two weeks after cryptococcosis
diagnosis, the patient underwent sur-
gery for staging. Histology of the
right middle lobe and pleura revealed
a granulomatous necrotizing infection
with C. neoformans (Fig. 1). One
month later, a thymectomy was per-
formed with partial pericardectomy,
followed by ICU admission for
1 month.
In summary, our patient showed
pulmonary cryptococcosis which,
due to negative bacteriological test-
ing, was not recognized as such.
Pulmonary signs were, therefore,
attributed to her thymoma. Despite
repeated testing for fungi of the
pleural effusion and BAL, these tests
remained negative during a sub-
stantial part of the disease
progression. Whether the initial
pleural transuduate was caused by
cryptococcal infection or that sec-
ondary infection of pre-existent
pleural fluid occurred, remains
unclear. Microbiologic examination
of specimens for cryptococci is not
always conclusive: the appearance of
cryptococci may vary considerably
Fig. 1 a Chest radiograph on
the day preceding surgery
showing significant pleural
effusion on the right hemithorax
and the thymoma in the left
hemithorax. b Haematoxylin
eosin (HE) staining of normal
lung tissue of our patient
(2009). c HE staining (2009)
of lung tissue with
Cryptococcus neoformans
infiltration showing a
granulomatous inflammation
with dense infiltrates of
lymphocytes, histocytes and
plasma cells. Focal presences of
cryptococcosis were seen
throughout the tissue biopsy
(see arrows, grey-blue
colorization, variable diameters
(4–20 lm), surrounded by a
clear zone)
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on gram-stained smears, and a posi-
tive smear should therefore always
be confirmed by culture. Negative
smears and cultures do not abso-
lutely rule out cryptococcosis whilst
antigen testing is false-negative in
40% of all extraneural cryptococco-
sis cases. Our findings underline that
an accurate diagnosis of cryptococ-
cosis remains problematic in patients
in whom signs and symptoms are
non-specific and often develop late
in the course of infection [2–4]. The
increased prevalence of fungal
infections warrants a high clinical
suspicion and urge for sensitive
detection tools, thereby decreasing
the incidence of a missed crypto-
coccosis diagnosis [4, 5].
In conclusion, pleural effusions
should raise the possibility of a
cryptococcal infection. Negative cul-
tures and smears of the pleural fluid
do not rule out this diagnosis. If
central nervous system infection with
cryptococcosis is present, one should
be aware of the fact that the lung is
the primary site of infection and
concomitant intrapulmonary and
pleural abnormalities should be eval-
uated with a high suspicion of
cryptococcal infection.
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